What is the current Ardelyx market capitalization?
The current market capitalization of Ardelyx is 1.34 B USD.
Ardelyx Market capitalization 2024
Ardelyx Market capitalization
1.34 B USD
Ticker
ARDX
ISIN
US0396971071
WKN
A116X0
In 2024, Ardelyx's market cap stood at 1.34 B USD, a 52.49% increase from the 881.71 M USD market cap in the previous year.
The Ardelyx Market capitalization history
| YEAR | Market Capitalization (undefined USD) |
|---|---|
| 2023 | 871.93 |
| 2022 | 169.32 |
| 2021 | 548.8 |
| 2020 | 574.93 |
| 2019 | 245.53 |
| 2018 | 252.06 |
| 2017 | 388.51 |
| 2016 | 427.84 |
| 2015 | 392.69 |
| 2014 | 345.78 |
| 2013 | - |
| 2012 | - |
Ardelyx Aktienanalyse
What does Ardelyx do?
Ardelyx Inc. is a biotechnology company founded in 2007 by researchers to develop life-changing medications. The company is based in Fremont, California, USA and focuses on researching kidney and gastrointestinal diseases, as well as cardiology and metabolic disorders. Its business model is based on identifying unmet medical needs and developing drugs to meet those needs. Ardelyx works closely with patients to understand their medical problems and develop specific solutions. The company categorizes its products into three categories: kidney, gastrointestinal, and cardiology/metabolism. Ardelyx has developed a medication called Tenapanor for chronic kidney disease, which reduces phosphorus levels in the blood, lowering the risk of cardiovascular disease. For gastrointestinal diseases like irritable bowel syndrome and ulcerative colitis, Ardelyx has developed Tenapanor to reduce pain and discomfort by regulating fluid and nutrient volumes in the intestine. In the field of cardiology/metabolic disorders, Ardelyx is working on developing medications to regulate cholesterol levels and the lipid metabolism system, which can be the cause of heart disease or diabetes. The company is awaiting approval for Ibsrela, a medication for chronic constipation and pelvic floor disorders, as well as RDX013, a medication to regulate lipid metabolism. Ardelyx also benefits from collaborating with other pharmaceutical companies, such as AstraZeneca, which has supported the development of novel treatments for kidney diseases. The partnership with AstraZeneca focuses on creating treatments that prevent damage to kidney cells or the cardiovascular system. Ardelyx has also received a number of awards and recognition, demonstrating its effectiveness and performance in the biotechnology industry. For example, in 2019, Inc. Magazine included Ardelyx for the fourth consecutive year in its list of the "5000 fastest-growing private companies in the USA." This publication highlighted Ardelyx's tripling of its employee count during the same period. Overall, Ardelyx focuses on researching and developing innovative medications that meet the needs of patients with kidney, gastrointestinal, cardiology, and metabolic disorders. Despite being a young company, it already produces a range of innovative products and is committed to developing life-changing medications through its research and improving the quality of life for affected patients. Output: Ardelyx Inc. is a biotechnology company focused on developing life-changing medications for kidney, gastrointestinal, cardiology, and metabolic disorders. They collaborate with patients to understand their medical problems and develop specific solutions. They have developed medications such as Tenapanor for chronic kidney disease and gastrointestinal diseases. They are awaiting approval for medications to treat chronic constipation and pelvic floor disorders, as well as regulate lipid metabolism. Ardelyx has partnerships with other pharmaceutical companies like AstraZeneca. They have received awards for their effectiveness and performance in the biotechnology industry. Ardelyx ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Ardelyx's Market Capitalization
Ardelyx's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Ardelyx's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Ardelyx's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Ardelyx’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Ardelyx stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Ardelyx.
How has the market capitalization of Ardelyx developed in recent years?
The market capitalization of Ardelyx has increased/decreased by 52.49% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Ardelyx?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Ardelyx?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Ardelyx have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Ardelyx pay?
Over the past 12 months, Ardelyx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ardelyx is expected to pay a dividend of 0 USD.
What is the dividend yield of Ardelyx?
The current dividend yield of Ardelyx is .
When does Ardelyx pay dividends?
Ardelyx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ardelyx?
Ardelyx paid dividends every year for the past 0 years.
What is the dividend of Ardelyx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ardelyx located?
Ardelyx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ardelyx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ardelyx from 9/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.
When did Ardelyx pay the last dividend?
The last dividend was paid out on 9/22/2024.
What was the dividend of Ardelyx in the year 2023?
In the year 2023, Ardelyx distributed 0 USD as dividends.
In which currency does Ardelyx pay out the dividend?
The dividends of Ardelyx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Ardelyx stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Ardelyx
Our stock analysis for Ardelyx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ardelyx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
